Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency.

Area of Science:

• Immunology
• Bone Biology
• Infectious Disease

Background:

• Sepsis is a life-threatening inflammatory response to infection, often leading to death due to lymphopenia-associated immunodeficiency.
• The mechanisms sustaining lymphopenia after initial lymphocyte death in sepsis remain unclear.

Purpose of the Study:

• To investigate the link between sepsis, bone cells, and persistent lymphopenia.
• To identify potential therapeutic targets within the bone system for sepsis-induced immune dysfunction.

Main Methods:

• Examined the impact of sepsis on osteoblasts and common lymphoid progenitors (CLPs) in a preclinical model.
• Investigated the effects of osteoblast ablation and interleukin-7 (IL-7) deletion on lymphopenia.
• Assessed the therapeutic potential of pharmacological osteoblast activation.

Main Results:

• Sepsis rapidly reduced osteoblast numbers, leading to a decrease in CLPs.
• Osteoblast dysfunction or IL-7 deficiency in osteoblasts mimicked sepsis-induced lymphopenia without affecting hematopoietic stem cells (HSCs).
• Activating osteoblasts pharmacologically ameliorated sepsis-induced lymphopenia.

Conclusions:

• Sepsis disrupts the reciprocal communication between the immune and bone systems by impairing osteoblasts.
• Osteoblast impairment results in lymphopenia and immunodeficiency during sepsis.
• Bone cells represent a potential therapeutic target for managing life-threatening immune responses like sepsis.